Mystic Pharmaceuticals has announced that it has received a notice of allowance from the China Patent Office for a patent application titled “Deep Draw Container Forming Method” (invention number ZL200880106965.1). The company also said that it received a notice of allowance for an application titled “Combination Unit Dose Dispensing Container” (application number 2010-508588) from the Japan Patent Office. Both patents are related to the VersiDoser and VRx2 delivery platforms, which can be used for intranasal delivery. Mystic recently received notices of allowance for two US patent applications related to the systems.
Mystic President and CEO Timothy Sullivan said, “Over the past decade, Mystic has innovated packaging and delivery technologies that enable the development of patient-centric pharmaceutical products. Japan and China along with several other global markets are high priority strategic opportunities for Mystic enhanced pharmaceutical drug/device combined products. These latest international patents reflect our long term commitment to developing the global market opportunity for our technology and products.”
Read the Mystic press release.
